Literature DB >> 8608680

High resolution computed tomography for the evaluation of lung involvement in 101 patients with scleroderma.

K Dévényi1, L Czirják.   

Abstract

The aim of the study was to investigate the pulmonary parenchymal abnormalities by high resolution computed tomography (HRCT) in patients with various forms of scleroderma. Three scans were performed sequentially in all cases: one at the level of aortic arch, one at the tracheal carina and one 1-2 cm above the diaphragm. Seventy cases with limited, 21 patients with diffuse cutaneous systemic sclerosis and 10 cases with circumscribed scleroderma were investigated. The 21 patients with diffuse scleroderma included three normal HRCT scan (14%), three with ground glass attenuation (14%), one with ground glass attenuation with fibrosis, three with fibrosis (14%), six with subpleural and five with diffuse honeycombing. The majority of cases with extensive honeycombing of the lungs had anti-Sc! 70 autoantibody which was the characteristic antibody of the diffuse scleroderma subset. The 70 cases with limited cutaneous systemic sclerosis were characterized by normal HRCT (43%), ground glass opacity with or without fibrosis (18.6%), whereas fibrosis was detected in 22.9%, subpleural or diffuse honeycombing in 15.7% of the patients. Six of the ten cases with circumscribed scleroderma also showed a fibrosis. Cases with diffuse scleroderma are characterized by the presence of advanced fibrosis, whereas the extent of fibrosis is far less pronounced in limited scleroderma. Mild fibrosis may also be present in circumscribed scleroderma forms.

Entities:  

Mesh:

Year:  1995        PMID: 8608680     DOI: 10.1007/bf02207928

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  29 in total

1.  Specific diagnosis by CT and HRCT in six chronic lung diseases.

Authors:  G Potente; A Bellelli; P Nardis
Journal:  Comput Med Imaging Graph       Date:  1992 Jul-Aug       Impact factor: 4.790

2.  Changes in pulmonary function in systemic sclerosis.

Authors:  L Czirják; E Szolnoki; Z Nagy; G Szegedi
Journal:  Postgrad Med J       Date:  1992-05       Impact factor: 2.401

3.  Clinical findings in 61 patients with progressive systemic sclerosis.

Authors:  L Czirják; A Bokk; G Csontos; G Lörincz; G Szegedi
Journal:  Acta Derm Venereol       Date:  1989       Impact factor: 4.437

4.  Chronic diffuse infiltrative lung disease: comparison of diagnostic accuracy of CT and chest radiography.

Authors:  J R Mathieson; J R Mayo; C A Staples; N L Müller
Journal:  Radiology       Date:  1989-04       Impact factor: 11.105

5.  Survival analysis of 118 patients with systemic sclerosis.

Authors:  L Czirják; Z Nagy; G Szegedi
Journal:  J Intern Med       Date:  1993-09       Impact factor: 8.989

6.  The presence of Sjögren's syndrome is a major determinant of the pattern of interstitial lung disease in scleroderma and other connective tissue diseases.

Authors:  S N Breit; D Cairns; A Szentirmay; T Callaghan; D Murray; T Wacher; P G Gibson; G Marks; D H Bryant; M Yeates
Journal:  J Rheumatol       Date:  1989-08       Impact factor: 4.666

7.  The predictive value of appearances on thin-section computed tomography in fibrosing alveolitis.

Authors:  A U Wells; D M Hansell; M B Rubens; P Cullinan; C M Black; R M du Bois
Journal:  Am Rev Respir Dis       Date:  1993-10

8.  High resolution computed tomography in early scleroderma lung disease.

Authors:  J H Warrick; M Bhalla; S I Schabel; R M Silver
Journal:  J Rheumatol       Date:  1991-10       Impact factor: 4.666

9.  [Study of high-resolution thoracic computerized tomography and bronchoalveolar lavage in 36 patients presenting with systemic disease and a normal thoracic radiography].

Authors:  E Dansin; B Wallaert; M Rémy-Jardin; T Perez; P Y Hatron; J Rémy; A B Tonnel
Journal:  Rev Mal Respir       Date:  1991       Impact factor: 0.622

10.  Mast cells' contribution to the fibrosing alveolitis of the scleroderma lung.

Authors:  P Chanez; J Y Lacoste; B Guillot; J Giron; G Barnéon; I Enander; P Godard; F B Michel; J Bousquet
Journal:  Am Rev Respir Dis       Date:  1993-06
View more
  1 in total

Review 1.  Scleroderma lung disease.

Authors:  Joshua J Solomon; Amy L Olson; Aryeh Fischer; Todd Bull; Kevin K Brown; Ganesh Raghu
Journal:  Eur Respir Rev       Date:  2013-03-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.